Stiolto respimat and Advair hfa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Stiolto respimat (olodaterol hydrochloride; tiotropium bromide) and Advair hfa (fluticasone propionate; salmeterol xinafoate). Common drug interactions include paraesthesia among females and atrial fibrillation among males.
The phase IV clinical study analyzes what interactions people have when they take Stiolto respimat and Advair hfa. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.
What is Stiolto respimat?
Stiolto respimat has active ingredients of olodaterol hydrochloride; tiotropium bromide. eHealthMe is studying from 4,438 Stiolto respimat users. Check the latest studies of Stiolto respimat.
What is Advair hfa?
Advair hfa has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 69,790 Advair hfa users. Check the latest studies of Advair hfa.
93 people who take Stiolto respimat and Advair hfa together, and have interactions are studied.

What are the common drug interactions of Stiolto Respimat and Advair Hfa, by gender? *:
female:
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Petechiae (a small red or purple spot caused by bleeding into the skin)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
- Rash erythematous (redness of the skin)
- Skin induration (an abnormally hard spot or area on the skin)
- Skin swelling
- Dyspnoea (difficult or laboured respiration)
- Hypersensitivity
male:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Drug ineffective
- Lung disorder (lung disease)
- Lung transplant
- Nephrolithiasis (calculi in the kidneys)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Productive cough
- Prostate infection
- Renal failure (kidney dysfunction)
- Renal injury (kidney injury)
What are the common drug interactions of Stiolto Respimat and Advair Hfa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Fatigue (feeling of tiredness)
40-49:
n/a
50-59:
- Drug hypersensitivity
- Loss of consciousness
- Malaise (a feeling of general discomfort or uneasiness)
- Mass
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Nausea (feeling of having an urge to vomit)
- Pneumonia
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Swollen tongue (swelling of tongue)
- Tooth infection
60+:
- Dyspnoea (difficult or laboured respiration)
- Heart rate increased
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
- Oedema peripheral (superficial swelling)
- Rash
- Abdominal distension
- Alopecia (absence of hair from areas of the body)
- Bladder irritation
What are the existing conditions these people have? *
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 26 people, 27.96%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 15 people, 16.13%
- Immunodeficiency Common Variable: 13 people, 13.98%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 10.75%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 9.68%
- Stress And Anxiety: 8 people, 8.60%
- Rashes (redness): 6 people, 6.45%
- Quit Smoking: 6 people, 6.45%
- Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 6 people, 6.45%
- Oropharyngitis Fungal (fungal infection of oropharynx): 6 people, 6.45%
* Approximation only. Some reports may have incomplete information.
Do you take Stiolto respimat and Advair hfa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Stiolto respimat (4,438 reports)
- Advair hfa (69,790 reports)
Browse all drug interactions of Stiolto respimat and Advair hfa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Stiolto respimat:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Advair hfa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Stiolto respimat and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Advair hfa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on olodaterol hydrochloride; tiotropium bromide and fluticasone propionate; salmeterol xinafoate (the active ingredients of Stiolto respimat and Advair hfa, respectively), and Stiolto respimat and Advair hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Kidney Transplant and Heart Palpitations - 2 seconds ago
- Could Bupropion Hydrobromide cause Weight Increased? - 5 seconds ago
- Could Gabapentin cause Medical Device Discomfort? - 23 seconds ago
- Could Symbicort cause International Normalised Ratio Abnormal? - 24 seconds ago
- Drug interactions of Zoledronic and Kanjinti - 34 seconds ago
- Drug interactions of Welchol and Bumetanide - 37 seconds ago
- Could Psyllium cause Gastroesophageal Reflux Disease? - 43 seconds ago
- Could Bumetanide cause Abnormal Loss Of Weight? - 44 seconds ago
- How effective is Tysabri for Multiple Sclerosis Relapse? - 46 seconds ago
- Could Lyrica cause Pancreatic Carcinoma? - 58 seconds ago